Home/Lisata Therapeutics/Kristen K. Buck, MD

KK

Kristen K. Buck, MD

Chief Medical Officer

Lisata Therapeutics

Therapeutic Areas

Lisata Therapeutics Pipeline

Drug	Indication	Phase
Certepetide (LSTA1)	Metastatic Pancreatic Ductal Adenocarcinoma	Phase 2b

Leadership Team at Lisata Therapeutics

David J. Mazzo, PhD

President & Chief Executive Officer

View full Lisata Therapeutics profile